Leveraging GNR Gold Nanorod
Sona’s GNR technology in Siva Therapeutics’
Len Pagliaro, PhD
Sona GNRs in targeted hyperthermia may create the opportunity to treat cancer without doing significant harm to healthy cells
Current Cancer Treatments are risky, expensive and can do harm
How does THT work?
Targeted Hyperthermia Therapy™ (THT)
Medical device with two components:
Heating tumors does the following:
Siva’s Unique Differentiator:
Selective ‘Hyperthermia’ Minimizes Collateral Damage
THT photothermal cancer therapy using GNRs will address current treatment issues
First THT Application: Colorectal Cancer Tumors
Why is THT uniquely suited for colorectal cancer treatment?
Read More About Targeted Hyperthermia
Road to Commercialization
Potential future clinical studies to provide multiple valuation catalysts.